Versant Venture Management, LLC Monte Rosa Therapeutics, Inc. Transaction History
Versant Venture Management, LLC
- $67.6 Million
- Q4 2024
A detailed history of Versant Venture Management, LLC transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Versant Venture Management, LLC holds 5,652,922 shares of GLUE stock, worth $34.5 Million. This represents 58.01% of its overall portfolio holdings.
Number of Shares
5,652,922Holding current value
$34.5 Million% of portfolio
58.01%Shares
1 transactions
Others Institutions Holding GLUE
# of Institutions
93Shares Held
44.6MCall Options Held
141KPut Options Held
31.2K-
Nea Management Company, LLC Timonium, MD7.69MShares$47 Million3.11% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$40.3 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.79MShares$35.4 Million0.46% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$30 Million0.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.16MShares$19.3 Million0.0% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $285M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...